A systematic review of lactate dehydrogenase isoenzyme 1 and germ cell tumors

Clinical Biochemistry

Volumn 34, Issue 6, 2001, Pages 441-454

  Von Eyben, Finn Edler ^a  

^a Center for Tobacco Research   (Denmark)

Author keywords

Alpha fetoproteins; Human chorionic gonadotropin; Lactate dehydrogenase; Lactate dehydrogenase isoenzymes; Metanalysis; Ovarian neoplasms; Testicular neoplasms

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; LACTATE DEHYDROGENASE ISOENZYME; TUMOR MARKER;

ARTICLE; BLOOD LEVEL; CANCER STAGING; ENZYME ASSAY; GERM CELL TUMOR; HUMAN; LITERATURE; MEDICAL RESEARCH; METASTASIS; NON SEMINOMATOUS GERMINOMA; OVARY; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; SEMINOMA; SURVIVAL RATE; TESTIS;

EID: 0034773023     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9120(01)00236-3     Document Type: Review

References (90)

1. Tumor marker utility grading system: Framework to evaluate clinical utility of tumor markers
2. Lactate dehydrogenase and its isoenzymes in testicular germ cell tumors: An overview
3. International germ cell concensus classification. A prognostic factor-based staging system for metastatic germ cell cancers
4. The 1963 Fiske essay - Enzyme activity in dysgerminoma and seminoma. A study of lactic dehydrogenase isoenzymes in malignant diseases
5. Serum lactate dehydrogenase isoenzyme 1 and tumour volume are indicators of response to treatment and predictors of prognosis in metastatic testicular germ cell tumours
6. Lactate dehydrogenase (LD) isoenzyme 1 is the most important LD isoenzyme in patients with testicular germ cell tumor
7. Serum lactate dehydrogenase isoenzyme 1 as a prognostic predictor for metastatic testicular germ cell tumours
8. Lactate dehydrogenase isoenzymes
9. Correcting for contamination from hemolysis in measurements of lactate dehydrogenase isoenzyme 1 in serum from patients with testicular germ cell tumors
10. Keynote addresses. Meta-analysis: Reconciling the results of independent studies
11. Calculating confidence intervals for relative risks, odds ratios, and standardised ratios and rates
12. The National Cancer Base Report on patterns of care for testicular carcinoma, 1985-1996
13. Surveillance alone versus radiotherapy after orchiectomy for clinical stage I nonseminomatous testicular cancer
14. Prognostic factors for relapse in stage I testicular seminoma treated with surveillance
15. Observation and expectant management for low-stage seminoma and nonseminoma
16. Surveillance following orchiectomy for seminoma of the testis
17. Clinical stage I nonseminoma: Surgery versus surveillance
18. Germ cell tumors: Staging, prognosis, and outcome
19. Resection of residual retroperitoneal masses in testicular cancer: Evaluation and improvement of selection criteria
20. Pathogenesis of adult testicular germ cell tumors. A cytogenetic model
21. Cytogenetics of a malignant ovarian germ-cell tumor
22. Isochromosomes in neoplasia
23. Chromosomal imbalance maps of malignant solid tumors: A cytogenetic survey of 3185 neoplasms
24. Absence of sperm-specific lactate dehydrogenase-X in patients with testis cancer
25. Lactate dehydrogenase isoenzyme 1 in testicular germ cell tumors
26. Lactate dehydrogenase isoenzyme 1 (LDH-1) in athymic mice with xenografts of a human testicular germ cell tumor
27. Human endodermal sinus tumor in nude mice and its markers for diagnosis and management
28. Carcinoma in situ of the testis and seminomas have a high protein level of lactate dehydrogenase subunit B and no subunit C
29. Differential expression of a human sperm-specific isoenzyme in seminoma cells transplanted in scid-nustr mice
30. Serum lactate dehydrogenase isoenzyme-1 activity in patients with testicular germ cell tumors correlates with the total number of copies of the short arms of chromosome 12 in the tumor
31. Total LDH activities and LDH isoenzyme patterns in the tissues of testicular tumors
32. Immunohistochemical localization of lactate dehydrogenase isoenzyme 1 in germ cell tumors of the testis
33. A comparative study of eight cell lines derived from human testicular teratocarcinoma
34. Ninth International Workshop on Human Gene Mapping. Human gene mapping 9
35. Rise of serum lactate dehydrogenase isoenzyme 1 (S-LD-1) correlates with tumour necrosis in stage I patients with testicular tumours
36. Additional lactate dehydrogenase (LDH) isoenzymes in normal testis and spermatozoa of adult man
37. Analytical quality specifications for serum lactate dehydrogenase isoenzyme 1 based on clinical goals
38. Serum lactate dehydrogenase isoenzyme 1 as a marker of testicular germ cell tumor
39. Analytical bias by contamination from hemolysis in determination of lactate dehydrogenase isoenzyme 1 in patients with testis germ cell tumors
40. Serum lactate dehydrogenase, alpha-hydroxybutyrate dehydrogenase and ratio of alpha-hydroxybutyrate dehydrogenase to lactate dehydrogenase in testicular tumours
41. Comparative study of the determination of alpha-hydroxybutyrate dehydrogenase, lactate dehydrogenase isoenzyme 1 LDH-1 by adsorption on DEAE Sephadex A-50 and electrophoresis
42. Serum lactate dehydrogenase (S-LDH) and S-LDH isoenzymes in patients with testicular germ cell tumors
43. Serum lactate dehydrogenase isoenzyme 1 in patients with advanced testicular cancer
44. Serum lactate dehydrogenase isoenzyme 1 and prediction of death of tumor in patients with metastatic testicular germ cell tumors
45. Recommended methods for determination of four enzymes in blood
46. Serum lactate dehydrogenase isoenzyme 1 and prediction of death of tumor in patients with metastatic testicular germ cell tumors
47. Serum lactate dehydrogenase isoenzyme 1 in patients with seminoma stage I followed with surveillance
48. Serum lactate dehydrogenase isoenzyme 1 and patients with nonseminomatous testicular germ cell tumors stage I
49. Approved recommendation on IFCC methods for the measurement of catalytic concentration of enzymes. Part 8. IFCC method for lactate dehydrogenase (L-Lactate: NAD+ Oxidoreductase, EC 1.1.1.27)
50. Serum lactate dehydrogenase and its isoenzymes in men with maldescended testes
51. Activity of lactate dehydrogenase in patients with malignant tumours of testis and ovary
52. Clinical applications of lactate dehydrogenase isoenzymes: Alterations in malignancy
53. Increased lactate dehydrogenase isoenzyme 1 in serum and tumor tissue of a patients with small-cell lung cancer
54. A clinical study of testicular tumors - Usefulness of serum lactic dehydrogenase (LDH)
55. High incidence of undetected neoplasia in maldescended testes
56. Serum lactate dehydrogenase isoenzyme 1 as predictor of tumor-associated death in patients with testicular germ cell tumours
57. Role of lactate dehydrogenase isoenzymes in testicular cancer
58. Serum lactate dehydrogenase isoenzyme 1 as an early indicator of relapse in patients with testicular germ cell tumors
59. Serum LDH activity and isoenzyme patterns in non seminomatous germinal (NSG) testis tumors
60. Use of LDH isoenzyme 1 as a serum marker for seminoma
61. Serum lactate dehydrogenase (LDH) isoenzyme 1 (LDH-1) and 2 (LDH-2) as tumor marker in germ cell tumors (GCT)
62. La lactate déshydrogénase plasmatique et ses isoenzymes dans les tumeurs germinales non séminomateuses du testicule
63. The management of metastatic testicular germ cell tumours and the clinical utility of lactate dehydrogenase estimations
64. Elevated lactate dehydrogenase isoenzyme 1 as a tumour marker in patients with germ cell testicular tumours
65. LDH and LDH isoenzymes in ovarian dysgerminoma
66. Analysis of serum CA125, CEA, AFP, LDH levels and LDH isoenzymes in patients with ovarian tumors - Correlation between tumor markers and histological types of ovarian tumors
67. Ovarian germinoma (dysgerminoma) with elevated serum lactic dehydrogenase: Case report and review of the literature
68. Serum lactic dehydrogenase and its isoenzymes in patients with ovarian dysgerminoma
69. Analysis of serum lactic dehydrogenase levels and its isoenzymes in ovarian dysgerminoma
70. Serum lactic dehydrogenase: A tumor marker for dysgerminoma
71. Significance of tumour markers in ovarian cancer
72. Serum lactate dehydrogenase isoenzyme-1 in children with yolk sac tumor
73. The value of cancer antigen-125 as a tumor marker in malignant germ cell tumors of the ovary
74. Total lactate dehydrogenase and its isoenzymes in serum from patients with primary carcinoma of the ovary
75. Retroperitoneal germinoma marked by elevated serum lactic dehydrogenase
76. Increased synthesis of lactate dehydrogenase "H" subunit by a malignant tumor
77. The clinical value of lactate dehydrogenase in serum: A quantitative review
78. Identification of the critical region of 12p over-representation in testicular germ cell tumors of adolescents and adults
79. Genetic aberrations in testicular germ cell tumors - A comparative genomic hybridization study
80. i(12p) in a malignant ovarian tumor
81. Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer